Skip to Content
Merck
  • Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.

Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.

Bioorganic & medicinal chemistry letters (2013-05-15)
Stephen P Muench, Jozef Stec, Ying Zhou, Gustavo A Afanador, Martin J McPhillie, Mark R Hickman, Patty J Lee, Susan E Leed, Jennifer M Auschwitz, Sean T Prigge, David W Rice, Rima McLeod
ABSTRACT

The enoyl acyl-carrier protein reductase (ENR) enzyme is harbored within the apicoplast of apicomplexan parasites providing a significant challenge for drug delivery, which may be overcome through the addition of transductive peptides, which facilitates crossing the apicoplast membranes. The binding site of triclosan, a potent ENR inhibitor, is occluded from the solvent making the attachment of these linkers challenging. Herein, we have produced 3 new triclosan analogs with bulky A- and B-ring motifs, which protrude into the solvent allowing for the future attachment of molecular transporters for delivery.